BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16365412)

  • 1. Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities.
    Takahashi T; Dejbakhsh-Jones S; Strober S
    J Immunol; 2006 Jan; 176(1):211-6. PubMed ID: 16365412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains.
    Exley M; Porcelli S; Furman M; Garcia J; Balk S
    J Exp Med; 1998 Sep; 188(5):867-76. PubMed ID: 9730888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood CD161+ T cells from asthmatic patients are activated during asthma attack and predominantly produce IFN-gamma.
    González-Hernández Y; Pedraza-Sánchez S; Blandón-Vijil V; del Río-Navarro BE; Vaughan G; Moreno-Lafont M; Escobar-Gutiérrez A
    Scand J Immunol; 2007 Apr; 65(4):368-75. PubMed ID: 17386028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of pro-inflammatory CD161(+) double negative (CD3(+)CD4(-)CD8(-)) T cells in AIDS patients is ameliorated by expansion of the γδ T cell population.
    Singleterry WL; Henderson H; Cruse JM
    Exp Mol Pathol; 2012 Feb; 92(1):155-9. PubMed ID: 22100877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased frequency of CD4+ cells expressing CD161 in cancer patients.
    Iliopoulou EG; Karamouzis MV; Missitzis I; Ardavanis A; Sotiriadou NN; Baxevanis CN; Rigatos G; Papamichail M; Perez SA
    Clin Cancer Res; 2006 Dec; 12(23):6901-9. PubMed ID: 17145807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD161 Is Expressed in a Subset of T-Cell Prolymphocytic Leukemia Cases and Is Useful for Disease Follow-up.
    Gilles SR; Yohe SL; Linden MA; Dolan M; Hirsch B; Grzywacz B
    Am J Clin Pathol; 2019 Sep; 152(4):471-478. PubMed ID: 31305900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD1d-independent developmental acquisition of prompt IL-4 gene inducibility in thymus CD161(NK1)-CD44lowCD4+CD8- T cells is associated with complementarity determining region 3-diverse and biased Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T cell receptor usage.
    Chen YT; Kung JT
    J Immunol; 2005 Nov; 175(10):6537-50. PubMed ID: 16272308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes.
    Lanier LL; Chang C; Phillips JH
    J Immunol; 1994 Sep; 153(6):2417-28. PubMed ID: 8077657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8(+)NKR-P1A (+)T cells preferentially accumulate in human liver.
    Ishihara S; Nieda M; Kitayama J; Osada T; Yabe T; Ishikawa Y; Nagawa H; Muto T; Juji T
    Eur J Immunol; 1999 Aug; 29(8):2406-13. PubMed ID: 10458753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells.
    Rosen DB; Cao W; Avery DT; Tangye SG; Liu YJ; Houchins JP; Lanier LL
    J Immunol; 2008 May; 180(10):6508-17. PubMed ID: 18453569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8
    Nicol B; Salou M; Vogel I; Garcia A; Dugast E; Morille J; Kilens S; Charpentier E; Donnart A; Nedellec S; Jacq-Foucher M; Le Frère F; Wiertlewski S; Bourreille A; Brouard S; Michel L; David L; Gourraud PA; Degauque N; Nicot AB; Berthelot L; Laplaud DA
    J Autoimmun; 2018 Mar; 88():61-74. PubMed ID: 29054368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age and CD161 expression contribute to inter-individual variation in interleukin-23 response in CD8+ memory human T cells.
    Shen H; Zhang W; Abraham C; Cho JH
    PLoS One; 2013; 8(3):e57746. PubMed ID: 23469228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.
    Bennett IM; Zatsepina O; Zamai L; Azzoni L; Mikheeva T; Perussia B
    J Exp Med; 1996 Nov; 184(5):1845-56. PubMed ID: 8920872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Th1/Th17 Functions of CD161+ CD8+ T Cells in Mucosal Tissues of Rhesus Macaques.
    Rout N
    PLoS One; 2016; 11(6):e0157407. PubMed ID: 27309719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor.
    Aldemir H; Prod'homme V; Dumaurier MJ; Retiere C; Poupon G; Cazareth J; Bihl F; Braud VM
    J Immunol; 2005 Dec; 175(12):7791-5. PubMed ID: 16339512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor.
    Rosen DB; Bettadapura J; Alsharifi M; Mathew PA; Warren HS; Lanier LL
    J Immunol; 2005 Dec; 175(12):7796-9. PubMed ID: 16339513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases.
    Mitsuo A; Morimoto S; Nakiri Y; Suzuki J; Kaneko H; Tokano Y; Tsuda H; Takasaki Y; Hashimoto H
    Rheumatology (Oxford); 2006 Dec; 45(12):1477-84. PubMed ID: 16638798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD161+ T (NT) cells exist predominantly in human intestinal epithelium as well as in liver.
    Iiai T; Watanabe H; Suda T; Okamoto H; Abo T; Hatakeyama K
    Clin Exp Immunol; 2002 Jul; 129(1):92-8. PubMed ID: 12100027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-type lectin-like CD161 is not a co-signalling receptor in gluten-reactive CD4 + T cells.
    Wyrożemski Ł; Sollid LM; Qiao SW
    Scand J Immunol; 2021 Jun; 93(6):e13016. PubMed ID: 33368526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of bronchoalveolar lavage T cell subsets in sarcoidosis on the basis of CD57, CD4 and CD8.
    Kurumagawa T; Seki S; Kobayashi H; Koike Y; Kanoh S; Hiraide H; Motoyoshi K
    Clin Exp Immunol; 2003 Sep; 133(3):438-47. PubMed ID: 12930372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.